Phillip J. Singer v. Kenneth Reali
883 F.3d 425
4th Cir.2018Background
- TranS1 sold the AxiaLIF spinal surgery system; its revenues depended heavily on insurers reimbursing procedures using CPT codes.
- In 2009 the AMA/NASS assigned the System a Category III CPT code (experimental), risking reimbursement; TranS1 publicly described efforts to secure reimbursement and to obtain Category I coding.
- Singer's complaint alleges TranS1 clandestinely encouraged surgeons to use Category I codes (or to "bury" Category III codes) to obtain improper reimbursements, and that TranS1 omited this scheme from SEC filings, press releases, and analyst calls.
- A relator filed a sealed False Claims Act qui tam suit in April 2011; DHHS subpoena issued in Oct. 2011; TranS1 disclosed the subpoena on Oct. 17, 2011; analyst report the next day tied the subpoena to reimbursement communications and noted ~half revenues came from use of Category I codes.
- TranS1's stock fell ~40% on Oct. 18, 2011. The qui tam later settled with the U.S. for $6M (TranS1 denied liability).
- District court dismissed the securities class complaint for failure to plead material misrepresentation and scienter (though it later found loss causation adequately alleged); Fourth Circuit vacated dismissal on misrepresentation and scienter and affirmed the loss-causation ruling, remanding for further proceedings.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Material misrepresentation/omission under §10(b) | Singer: TranS1 spoke about reimbursement efforts, creating a duty to disclose the fraudulent coding scheme; omissions rendered statements misleading and were material. | TranS1: It disclosed Category III coding and described reimbursement efforts; no duty to confess unadjudicated wrongdoing; warnings in 10-Ks cured any omission. | Court: Vacated dismissal — pleading sufficiently alleges materially misleading statements/omissions because TranS1's affirmative statements about reimbursement made nondisclosure misleading and the omitted scheme was material. |
| Scienter (intent or severe recklessness) | Singer: Scheme was central to revenues and obviously illegal; omissions and selective disclosures give rise to a strong inference of scienter. | TranS1: Complaint lacks particularized facts showing officers knew the scheme or its illegality; disclosures show transparency, not deception. | Court: Vacated dismissal — allegations, read holistically, permit a strong inference of recklessness/intent as to TranS1 and officers. |
| Loss causation (corrective disclosure / materialized risk) | Singer: Oct. 17 Form 8-K (DHHS subpoena) + Oct. 18 analyst report revealed the reimbursement scheme and caused the stock plunge. | TranS1: Disclosures were merely an investigation notice and speculative analyst commentary; plaintiff fails to tie revelations to fraud-caused loss. | Court: Affirmed district court — the 8-K plus analyst report, taken together, disclosed the concealed risk/partial corrective information and plausibly caused the >40% price drop. |
| Derivative control-person liability under §20(a) | Singer: Officers controlled TranS1 and thus are liable if §10(b) liability is established. | TranS1: §20(a) depends on §10(b); dismissal warranted if §10(b) fails. | Court: Because §10(b) survived, §20(a) remains viable; district-court dismissal of §20(a) remandable (court did not resolve control issues). |
Key Cases Cited
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (overview of scienter and PSLRA "strong inference" standard)
- Dura Pharm., Inc. v. Broudo, 544 U.S. 336 (loss causation requires the "relevant truth" to leak out)
- Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (limits on affirmative duty to disclose; companies must avoid making statements that are misleading in context)
- Basic, Inc. v. Levinson, 485 U.S. 224 (silence not misleading absent a duty to disclose)
- Katyle v. Penn Nat'l Gaming, Inc., 637 F.3d 462 (loss causation standards; corrective disclosure v. materialization of concealed risk)
- U.S. S.E.C. v. Pirate Inv'r LLC, 580 F.3d 233 (materiality and deceptive acts under §10(b))
- Meyer v. JinkoSolar Holding Co., 761 F.3d 245 (generic risk warnings do not immunize failure to disclose known, material facts)
- Zak v. Chelsea Therapeutics Int'l, Ltd., 780 F.3d 597 (recklessness may satisfy scienter; context of omissions and selective disclosures)
- In re Vivendi, S.A. Sec. Litig., 838 F.3d 223 (loss causation inquiry whether misstatement concealed something that when revealed lowered stock value)